Atropine Sulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Hospira, Inc., a Pfizer Company with status To Be Discontinued. The shortage was first posted on 11/07/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-4910-34
- Dosage Form
- Injection
- Presentation
- Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)"
- Initial Posting
- 11/07/2025
- Revised Date